JeffcoateSL. Analytical and clinical significance of peptide hormone heterogeneity with particular reference to growth hormone and luteinizing hormone in serum. Clin Endocr1993; 38: 113–21.
2.
EkinsRP. Immunoassay Standardization. Proceedings of the 3rd IFCC/Bergmeyer Conference on Improvement of Comparability of Laboratory Assay Results in Life Sciences. Scand J Clin Lab Invest1991; 51(Suppl 205): 33–46.
3.
National Institute for Biological Standards and Control.Catalogue of Biological Standards and Reference Materials. Hertfordshire; UK: NIBSC, 1994.
4.
StorringPL. Assaying glycoprotein hormones—the influence of glycosylation on immunoreactivity. Tibtech1992; 10: 427–31.
5.
BristowAFDasGaines RJeffcoateSLSchulsterD.The first international standard for somatropin, report of an International Collaborative Study. Growth Regulat1995; 5: 133–41.
6.
SethJEllisARSturgeonCMAl SadieR.The external quality assessment of peptide hormone assays in the 1990s: scientific problems and priorities. In: Proc UK NEQAS Endocrinol Meet, Edinb 19941995; 1: 205–9.
7.
BidartJM. Functional mapping of proteins with monoclonal antibodies. In: GoslingJPGreenDJ, eds. ImmunotechnologyLondon: Portland Press, 1993.
8.
PetterssonKDingY-QHuhtaniemiI.Monoclonal antibody-based discrepancies between two-site immunometric tests for Lutropin. Clin Chem1991; 10: 1745–8.
9.
BeckettGJWilkinsonEMcIverBRaePWHGrantDRayDCRecent developments in thyroid function testing. InProc UK NEQAS Endocrin Meet Edinb 19941995; 1: 149–55.
10.
RobertsonWRMitchellR.Bioassays and Immunoassays: Resolving the differences. InProc UK NEQAS Endocrinol Meet Edinb1994; 1: 1–11.
